News | December 10, 2008

Heart Rhythm Society Says Measures Are In Place to Ensure Safety of EP Devices

December 11, 2008 - The Heart Rhythm Society is reiterating its position on the importance of device and lead reliability and safety following the publication of “Learning from Our Mistakes? Testing New ICD Technology” by Robert Hauser, M.D., and Adrian Almquist, M.D., as well as a corresponding letter from Mitchell Shein and Daniel Schultz from the FDA, which were published in the Dec. 11 issue of the New England Journal of Medicine.

“The Heart Rhythm Society is committed to the highest standard of patient safety,” said N.A. Mark Estes, president of the Heart Rhythm Society. “We have been at the forefront of establishing policies and guidelines to ensure the safety of life-saving devices such as internal cardiac defibrillators (ICDs) and pacemakers. The society will continue to develop standards as technology continues to evolve.”

To address issues regarding the safety of device leads, the Heart Rhythm Society created a task force earlier this year with leading experts and is currently collaborating with regulatory agencies, industry and patients to develop recommendations regarding lead performance. The Heart Rhythm Society anticipates releasing the new recommendations at Heart Rhythm 2009, the society’s annual scientific sessions which will take place in Boston in May.

The society’s recommendations for the surveillance, analysis and performance reporting of pacemakers and implantable cardioverter defibrillators (ICDs), released in September 2006, have been adopted by physicians, government and industry and helped to achieve greater transparency in the post-market surveillance, analysis and reporting of information; the establishment of new systems to identify malfunctioning devices more quickly; and standard notification and communication to physicians and patients from the manufacturer when a device malfunction is identified.

For more information: www.HRSonline.org

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
Overlay Init